RecruitingNCT07165535
Quality of Life and Care Organization of Patients With Chronic Myeloid Leukemia in the Lombardy Hematology Network
Sponsor
University of Milano Bicocca
Enrollment
2,000 participants
Start Date
Apr 17, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
The primary objective of the study is to assess the impact of the organizational model of the hematology center on the quality of life of patients with CML estimated through standardized tools (EORTC QLQ-30, CML24) and through the patient's opinion regarding aspects of the quality of care.
Eligibility
Min Age: 18 Years
Inclusion Criteria5
- Subjects aged 18 years or older.
- Subjects diagnosed with Chronic Myeloid Leukemia.
- Subjects diagnosed with CML under care at the hematology outpatient clinics of the 21 REL centers.
- Subjects followed at the reference hematology center for a minimum of 6 months.
- Freely given informed consent obtained before the start of the study.
Exclusion Criteria1
- Subjects who have not given consent to participate in the study.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07165535
Related Trials
A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies
NCT055898969 locations
Open-label Study of Asciminib for CML-CP or CML-AP Patients With T315I Mutation Who Are Resistant, Intolerant or Ineligible to Ponatinib.
NCT065145342 locations
Chronic Myeloid Leukemia (CML) Real-Life Database
NCT0596306114 locations
EPIgenetics and in Vivo Resistance of Chronic Myeloid Leukemia Stem Cells to Tyrosine Kinase Inhibitors
NCT0348186816 locations